Boothbay Fund Management’s OptimizeRx OPRX Stock Holding History

Boothbay Fund Management’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-73,488	Closed	-$901K	–	2369
2025 Q4	$901K	Buy	73,488 +25,502	+53%	+$417K	0.01%	838
2025 Q3	$984K	Buy	+47,986	New	+$761K	0.01%	845
2025 Q1	–	Sell	-28,875	Closed	-$140K	–	1675
2024 Q4	$140K	Sell	28,875 -22,189	-43%	-$124K	﹤0.01%	1243
2024 Q3	$394K	Sell	51,064 -54,329	-52%	-$483K	0.01%	1094
2024 Q2	$1.05M	Buy	105,393 +14,916	+16%	+$164K	0.03%	699
2024 Q1	$1.1M	Sell	90,477 -34,751	-28%	-$504K	0.02%	728
2023 Q4	$1.79M	Buy	125,228 +71,399	+133%	+$685K	0.05%	533
2023 Q3	$419K	Buy	+53,829	New	+$586K	0.01%	1114
2021 Q4	–	Sell	-29,779	Closed	-$2.55M	–	2126
2021 Q3	$2.55M	Buy	+29,779	New	+$1.87M	0.07%	360

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boothbay Fund Management's OPRX Position: Q1 2026 in Review

Boothbay Fund Management sold out of OptimizeRx (OPRX) in Q1 2026, closing a stake of 73,488 shares — an estimated $901K sold.

Boothbay Fund Management first reported a position in OPRX in Q3 2021 and held it in 9 quarters. The position peaked at $2.55M in Q3 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

Boothbay Fund Management reported no remaining OptimizeRx position as of Q1 2026 after selling out during the quarter.
Boothbay Fund Management sold 73,488 OptimizeRx shares in Q1 2026, an estimated $901K.
Boothbay Fund Management first reported a position in OptimizeRx in Q3 2021 and held it in 9 quarters.
Boothbay Fund Management's OptimizeRx position peaked at $2.55M in Q3 2021.
128 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.